| | Patients with inducible VT/VF (*) | Patients without inducible VT/VF (*) |
p-values
|
|---|
n
| 12 | 26 | |
male gender
| 7 | 17 |
0.45
|
age
| 60 ± 11 | 54 ± 16 |
0.34
|
EF (%)
| 58 ± 13 | 59 ± 10 |
0.81
|
EDM (g)
| 202 ± 58 | 195 ± 59 |
0.32
|
EDV (ml)
| 169 ± 60 | 150 ± 48 |
0.32
|
ESV (ml)
| 75 ± 45 | 63 ± 26 |
0.31
|
SV (ml)
| 94 ± 29 | 85 ± 30 |
0.41
|
LVEDD (mm)
| 50 ± 9 | 51 ± 7 |
0.85
|
SWT (mm)
| 22 ± 4 | 19 ± 5 |
0.13
|
PWT (mm)
| 10 ± 3 | 11 ± 4 |
0.34
|
RVEDD (mm)
| 44 ± 5 | 43 ± 7 |
0.63
|
RVSD (mm)
| 27 ± 7 | 28 ± 6 |
0.45
|
Presence
of LGE
| 10/12 (83%) | 15/26 (58%) |
0.12
|
% of LV mass with LGE
| 22% | 10% |
0.03
|
- (*) 38 of 43 High risk patients underwent EP-testing; EDM = enddiastolic mass; EDV = enddiastolic volume; EF = left ventricular ejection fraction; ESV = endsystolic volume; LGE = Late gadolinium enhancement; Extent of LGE(%) = Extent of LGE expressed as a percentage of total myocardium; Presence of LGE = Number of patients in whom LGE was detectable (irrespective of extent); Segments with LGE = Number of segments according to the AHA 17-segments system that show LGE; LVEDD = left ventricular enddiastolic diameter; PWT = posterior-wall-thickness; RVEDD = right ventricular enddiastolic diameter; RVESD = right ventricular endsystolic diameter; SV = stroke volume; SWT = Septal-wall-thickness; (Mean value ± standard deviation).
